S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
LON:THRL

Target Healthcare REIT (THRL) Share Forecast, Price & News

GBX 109.20
+1.40 (+1.30%)
(As of 05/13/2022 12:00 AM ET)
Add
Compare
Today's Range
108.60
109.80
50-Day Range
105.60
117.60
52-Week Range
103.80
126
Volume
567,001 shs
Average Volume
1.25 million shs
Market Capitalization
£677.30 million
P/E Ratio
12.55
Dividend Yield
6.12%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive THRL News and Ratings via Email

Sign-up to receive the latest news and ratings for Target Healthcare REIT and its competitors with MarketBeat's FREE daily newsletter.

Target Healthcare REIT logo

About Target Healthcare REIT

Target Healthcare REIT provide a range of tailored funding solutions to support operators to increase the provision of modern, purpose-built care homes across the UK.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
REIT—Healthcare Facilities
Sub-Industry
N/A
Sector
Finance
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
£51.62 million
Cash Flow
GBX 5.57 per share
Book Value
GBX 110.90 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£677.30 million
Optionable
Not Optionable

Company Calendar

Ex-Dividend for 2/25 Dividend
2/10/2022
Dividend Payable
2/25/2022
Ex-Dividend for 5/27 Dividend
5/12/2022
Today
5/15/2022
Dividend Payable
5/27/2022

MarketRank

Overall MarketRank

2.04 out of 5 stars

Analyst Opinion: 1.0Community Rank: 4.4Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -













Target Healthcare REIT (LON:THRL) Frequently Asked Questions

Is Target Healthcare REIT a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Target Healthcare REIT in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Target Healthcare REIT stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in THRL, but not buy additional shares or sell existing shares.
View analyst ratings for Target Healthcare REIT
or view top-rated stocks.

How often does Target Healthcare REIT pay dividends? What is the dividend yield for Target Healthcare REIT?

Target Healthcare REIT announced a dividend on Thursday, May 5th. Shareholders of record on Thursday, May 12th will be paid a dividend of GBX 1.69 per share on Friday, May 27th. This represents a yield of 1.55%. The ex-dividend date is Thursday, May 12th. The official announcement can be accessed at this link.
View Target Healthcare REIT's dividend history
.

Is Target Healthcare REIT a good dividend stock?

Target Healthcare REIT pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 6.12%. THRL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Target Healthcare REIT is 0.77%. This payout ratio is at a healthy, sustainable level, below 75%.
View Target Healthcare REIT's dividend history.

What price target have analysts set for THRL?

1 brokerages have issued 12-month target prices for Target Healthcare REIT's shares. Their forecasts range from GBX 120 to GBX 120. On average, they expect Target Healthcare REIT's stock price to reach GBX 120 in the next twelve months. This suggests a possible upside of 9.9% from the stock's current price.
View analysts' price targets for Target Healthcare REIT
or view top-rated stocks among Wall Street analysts.

Who are Target Healthcare REIT's key executives?
Target Healthcare REIT's management team includes the following people:
  • Mr. Kenneth Macangus MacKenzie C.A., M.A., MA CA, Founder & Chief Exec. of Target Fund Mang.s Limited (Age 72)
  • Mr. Gordon Bland BAcc CA, C.A., Fin. Director of Target Fund Mang.s Limited
  • Mr. John Flannelly BAcc FCA, F.C.A., Head of Investment - Target Fund Mang.s Limited
  • Mr. Andrew Brown, Head of Healthcare - Target Fund Mang.s Limited
  • Mr. Scott Steven M.A., Head of Asset Management - Target Fund Mang.s Limited
  • Mr. Donald Cameron B.Com., C.A., Company Sec. & Director of Financial Reporting - Target Fund Mang.s Limited
What other stocks do shareholders of Target Healthcare REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Target Healthcare REIT investors own include Cambian Group (CMBN), Realty Income (O), Empiric Student Property (ESP), BHP Group (BHP), Black Box (BBOX), Bayer Aktiengesellschaft (BAYN), Basf (BASFY), Bank of America (BAC), Boeing (BA) and Adtalem Global Education (ATGE).

What is Target Healthcare REIT's stock symbol?

Target Healthcare REIT trades on the London Stock Exchange (LON) under the ticker symbol "THRL."

How do I buy shares of Target Healthcare REIT?

Shares of THRL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Target Healthcare REIT's stock price today?

One share of THRL stock can currently be purchased for approximately GBX 109.20.

How much money does Target Healthcare REIT make?

Target Healthcare REIT has a market capitalization of £677.30 million and generates £51.62 million in revenue each year.

What is Target Healthcare REIT's official website?

The official website for Target Healthcare REIT is www.targethealthcarereit.co.uk.

How can I contact Target Healthcare REIT?

Target Healthcare REIT's mailing address is Ordnance House, 31 Pier Road, SAINT HELIER, JE4 8PW, Jersey. The company can be reached via phone at +44-131-6252951.

This page was last updated on 5/15/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.